Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adipose-derived mesenchymal stem cell injection for knee osteoarthritis
IRCT20210307050611N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Apr 2021
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of adipose derived mesenchymal stromal cells in knee osteoarthritis (OA) (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Cartilage thickness, Pain and 1 more. Started Apr 2021; status: completed.
02
Drugs
adipose derived mesenchymal stromal cells
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on IRCT20210307050611N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210307050611N1.